BIOMAT Database Logo BIOMAT Database Logo

CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis. 2013

Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden. andreas.carlborg@sll.se

Relationships between concentrations of cerebrospinal fluid (CSF) kynurenic acid (KYNA) and suicidal behavior were evaluated in 59 patients with psychosis after 22 years of follow-up. Three patients died from suicide and nine patients had a history of attempted suicide. Patients with attempted suicide had significantly lower concentrations of CSF KYNA.

UI MeSH Term Description Entries
D007736 Kynurenic Acid A broad-spectrum excitatory amino acid antagonist used as a research tool. Kynurenate,Acid, Kynurenic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Kynurenic acid and schizophrenia.
January 2003, Advances in experimental medicine and biology,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Suicide prevention in schizophrenia spectrum disorders and psychosis: a systematic review.
January 2013, BMC psychology,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
May 2012, Schizophrenia bulletin,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
CSF 5-hydroxyindoleacetic acid levels and suicide attempts in schizophrenia.
April 1990, Biological psychiatry,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Diagnostic profile and suicide risk in schizophrenia spectrum disorder.
November 2010, Schizophrenia research,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Distress intolerance, kynurenic acid, and schizophrenia.
July 2014, JAMA psychiatry,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Serum kynurenic acid is reduced in affective psychosis.
May 2017, Translational psychiatry,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
The kynurenic acid hypothesis of schizophrenia.
September 2007, Physiology & behavior,
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Suicide risk assessment and risk of suicide in schizophrenia.
April 2014, Psychiatric services (Washington, D.C.),
Andreas Carlborg, and Jussi Jokinen, and Erik G Jönsson, and Sophie Erhardt, and Peter Nordström
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.
July 2017, Schizophrenia bulletin,
Copied contents to your clipboard!